Global Pharma Health Fund
| Global Pharma Health Fund eV (GPHF eV) |
|
|---|---|
|
|
| purpose | Combating counterfeit medicines |
| Chair: | Johannes Waltz |
| Establishment date: | 2007 |
| Number of members: | 9 |
| Seat : | Frankfurt am Main |
| Website: | www.gphf.org |
The Global Pharma Health Fund eV (GPHF) is a non-profit association for the promotion of the health system with a special focus on development cooperation. The aim of the association is currently the fight against counterfeit drugs .
With the help of a mobile compact laboratory specially developed for this purpose - the GPHF-Minilab - counterfeit drugs are to be detected quickly in developing countries in order to protect the health of the local population. The GPHF concept has been taken up in over 90 countries worldwide. Over 800 of the mobile compact laboratories are currently (as of January 2017) in use.
The successful fight against counterfeit medicines requires international cooperation. The work of the GPHF is supported by networks with multilateral partners as well as local project champions at the state and non-state level. International partners include the World Health Organization (WHO), the Pharmacopeial Convention (USP) and Management Sciences for Health (MSH), with USP and MSH mainly providing technical assistance. Additional support comes from the German Society for Technical Cooperation (GTZ) and church institutions such as the Mission Medical Institute in Würzburg, the German drug aid organization action medeor and the German Doctors .
history
The "Global Pharma Health Fund eV" goes back to the "German Pharma Health Fund eV" From 1985 to 2007 it carried out projects to improve health care in developing countries. Many of them still serve as models today, with the fight against counterfeit drugs already being a significant part of the project work of the “German Pharma Health Fund eV”. From 1996 the concept of a portable small laboratory was put into practice. The aim was to provide developing countries with practical and inexpensive help to control the medicines there and to offer the health services and the population an initial protection against counterfeit medicines.
The minilab was developed over several years by the GPHF project manager Richard Jähnke and tested for its practicality in the Philippines , Kenya , Ghana and Tanzania before it was presented to the public in 1998. Since then, it has been expanded in several steps, so that today many important drugs offered in developing countries can be investigated. The focus of the investigations is on the drug group of life-saving anti-infectives z. B. for the treatment of malaria , TB and HIV / AIDS but also simple antibiotics from paediatrics, which, if falsified, stretched and adulterated, can be directly life-threatening for the patient. After 11 years of successful work, the Minilab project became the sponsorship of the new “Global Pharma Health Fund eV” in 2007.
Board of Directors, Financing and Partners
The CEO of the Global Pharma Health Fund eV (GPHF) is Friederike Segeberg, her deputy is Frank Gotthardt. The GPHF is a registered association that has been working on a non-profit basis since it was founded and is recognized accordingly by the tax authorities. In particular, the pharmaceutical and chemical company Merck supports the association financially. The GPHF's project work is also supported with the company's donations.
The GPHF minilab
The World Health Organization (WHO) assumes that up to ten percent of the drugs offered worldwide are counterfeit or technically inferior. Counterfeit drugs pose a serious threat to health care in all countries. Monitoring drug supplies to protect consumers is playing an increasingly important role, especially in developing countries, because they bear the brunt of the threat and are poorly prepared. Regular checks are currently unavoidable in order to be able to detect forgeries on site. Modern pharmacopoeia analysis requires complicated and expensive test methods for this. In developing countries, however, there are currently hardly any institutions that can cope with these tasks with the required intensity. In order to overcome bottlenecks at the drug supervisory authorities as well as at state, private and church drug supply institutions, the GPHF therefore developed the concept of a mobile compact laboratory for the rapid detection of counterfeit drugs and has since made it available at low cost for all public and private health services far below the total cost.
The main areas of application of the minilab are in Africa , Asia and Latin America . These are the regions that are particularly often affected by counterfeit medicines. Numerous laboratories work, for example, in Cambodia , Laos , Vietnam , Bolivia , Colombia , Nigeria , Ghana and the Congo . In Tanzania , a comprehensive monitoring system was set up with a total of 25 minilabs.
Individual evidence
- ↑ [1] (PDF; 605 kB). Essential Medicines and Pharmaceutical Policy.
- ↑ [2] ( Page no longer available , search in web archives ) Info: The link was automatically marked as defective. Please check the link according to the instructions and then remove this notice. . Liberia begins monitoring the quality of their medicines.
- ↑ Archive link ( Memento of the original from September 25, 2006 in the Internet Archive ) Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice. (PDF; 210 kB). SEAM Tanzania.
- ↑ [3]. Article “Help for pharmacies in Africa”. Retrieved December 7, 2010.
- ↑ Archive link ( Memento of the original from September 23, 2015 in the Internet Archive ) Info: The archive link has been inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice. Article "Minilab exposes counterfeit medicines in Kyrgyzstan". Retrieved December 3, 2010.
- ↑ Archive link ( Memento of the original from March 4, 2016 in the Internet Archive ) Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice. .Article "GPHF-Minilab to catch counterfeits in Haiti". Retrieved December 7, 2010.
